Today’s news reports address:
- Barbers as prostate risk educators in the black community
- The need for a Phase III trial of docetaxel + carboplatin in CRPC … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: barber, carboplatin, castration-resistant prostate cancer, CRPC, docetaxel, educator, risk | Leave a comment »